- Home
- NTIC vs WHWK Comparison
NTIC vs WHWK Comparison
Compare NTIC & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTIC
- WHWK
- Stock Information
- Founded
- NTIC 1970
- WHWK 2007
- Country
- NTIC United States
- WHWK United States
- Employees
- NTIC N/A
- WHWK N/A
- Industry
- NTIC Industrial Specialties
- WHWK Biotechnology: Pharmaceutical Preparations
- Sector
- NTIC Industrials
- WHWK Health Care
- Exchange
- NTIC Nasdaq
- WHWK Nasdaq
- Market Cap
- NTIC 73.7M
- WHWK 82.4M
- IPO Year
- NTIC N/A
- WHWK N/A
- Fundamental
- Price
- NTIC $7.76
- WHWK $1.99
- Analyst Decision
- NTIC
- WHWK
- Analyst Count
- NTIC 0
- WHWK 0
- Target Price
- NTIC N/A
- WHWK N/A
- AVG Volume (30 Days)
- NTIC 14.5K
- WHWK 115.5K
- Earning Date
- NTIC 07-10-2025
- WHWK 08-07-2025
- Dividend Yield
- NTIC 0.51%
- WHWK N/A
- EPS Growth
- NTIC N/A
- WHWK N/A
- EPS
- NTIC 0.31
- WHWK N/A
- Revenue
- NTIC $85,268,129.00
- WHWK $21,596,000.00
- Revenue This Year
- NTIC $1.09
- WHWK N/A
- Revenue Next Year
- NTIC $5.69
- WHWK N/A
- P/E Ratio
- NTIC $25.20
- WHWK N/A
- Revenue Growth
- NTIC 3.46
- WHWK N/A
- 52 Week Low
- NTIC $6.75
- WHWK $1.39
- 52 Week High
- NTIC $15.09
- WHWK $3.81
- Technical
- Relative Strength Index (RSI)
- NTIC 52.74
- WHWK 66.97
- Support Level
- NTIC $7.75
- WHWK $1.78
- Resistance Level
- NTIC $8.09
- WHWK $2.04
- Average True Range (ATR)
- NTIC 0.19
- WHWK 0.08
- MACD
- NTIC 0.06
- WHWK 0.03
- Stochastic Oscillator
- NTIC 60.71
- WHWK 85.29
About NTIC Northern Technologies International Corporation
Northern Technologies International Corp, or NTIC is a United States-based firm that develops and markets environmentally beneficial products and services world-wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company.
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.